BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22535678)

  • 1. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
    Williams D; Rao M; Carey P
    J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
    Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
    Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
    Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
    Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.
    Triulzi DJ; Kleinman S; Kakaiya RM; Busch MP; Norris PJ; Steele WR; Glynn SA; Hillyer CD; Carey P; Gottschall JL; Murphy EL; Rios JA; Ness PM; Wright DJ; Carrick D; Schreiber GB
    Transfusion; 2009 Sep; 49(9):1825-35. PubMed ID: 19453983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil.
    Blatyta PF; Custer B; Liu J; Mendrone-Junior A; Wright DJ; Leão SC; Lopes MI; Carneiro-Proietti AB; Sabino EC; de Almeida-Neto C;
    Transfus Apher Sci; 2013 Feb; 48(1):15-20. PubMed ID: 22985535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
    Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
    Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure.
    Rios JA; Schlumpf KS; Kakaiya RM; Triulzi DJ; Roback JD; Kleinman SH; Murphy EL; Gottschall JL; Carey PM;
    Transfusion; 2011 Jun; 51(6):1197-206. PubMed ID: 21182532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of specificities of antibodies against human leukocyte antigens in blood donors.
    Endres RO; Kleinman SH; Carrick DM; Steele WR; Wright DJ; Norris PJ; Triulzi D; Kakaiya R; Busch MP;
    Transfusion; 2010 Aug; 50(8):1749-60. PubMed ID: 20158682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
    Lin Y; Saw CL; Hannach B; Goldman M
    Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
    van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
    Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographics of apheresis platelet donors in five blood centers in China.
    Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Liu J; Wright DJ; Shan H;
    Transfusion; 2012 Mar; 52(3):560-6. PubMed ID: 21895674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.